These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8004883)

  • 41. [Image and quantity analysis of prostaglandin in rats' blood plasma and Na(+)-K(+)-ATPase in their cerebellum during the prevention of motion sickness by cinnarizine].
    Dong W; Tian D; Zhang M
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 1998 Jun; 15(2):151-4. PubMed ID: 12548903
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of a portable acustimulation device in controlling seasickness.
    Bertolucci LE; DiDario B
    Aviat Space Environ Med; 1995 Dec; 66(12):1155-8. PubMed ID: 8747609
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of the effects of anti-motion sickness drugs on subjective sleepiness and cognitive performance of healthy males.
    Weerts AP; Pattyn N; Van de Heyning PH; Wuyts FL
    J Psychopharmacol; 2014 Jul; 28(7):655-64. PubMed ID: 24346808
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Salivary changes associated with seasickness.
    Gordon CR; Ben-Aryeh H; Szargel R; Attias J; Rolnick A; Laufer D
    J Auton Nerv Syst; 1989 Feb; 26(1):37-42. PubMed ID: 2708783
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and tolerability of a fixed low-dose combination of cinnarizine and dimenhydrinate in the treatment of vertigo: a 4-week, randomized, double-blind, active- and placebo-controlled, parallel-group, outpatient study.
    Pytel J; Nagy G; Tóth A; Spellenberg S; Schwarz M; Répassy G
    Clin Ther; 2007 Jan; 29(1):84-98. PubMed ID: 17379049
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Motion Sickness and Resting Energy Expenditure in Chinese Male Adults.
    Wang JQ; Qi RR; Pan LL; Zhou W; Zhang LL; Cai YL
    Aerosp Med Hum Perform; 2016 Apr; 87(4):360-6. PubMed ID: 27026119
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cinnarizine for Sea Sickness During a Remote Pacific Ocean Rescue Mission.
    Lyon RF; Rush SC; Roland T; Jethanamest D; Schawn CP; Kharod C
    J Spec Oper Med; 2015; 15(2):1-6. PubMed ID: 26125158
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Neurophysiology and Treatment of Motion Sickness.
    Koch A; Cascorbi I; Westhofen M; Dafotakis M; Klapa S; Kuhtz-Buschbeck JP
    Dtsch Arztebl Int; 2018 Oct; 115(41):687-696. PubMed ID: 30406755
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optokinetic stimulation rehabilitation in preventing seasickness.
    Trendel D; Haus-Cheymol R; Erauso T; Bertin G; Florentin JL; Vaillant PY; Bonne L
    Eur Ann Otorhinolaryngol Head Neck Dis; 2010 Sep; 127(4):125-9. PubMed ID: 20860921
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Change in susceptibility to vestibular-visual conflict sickness in monkeys by repeated exposure.
    Igarashi M; Kobayashi K; Kulecz WB; Himi T
    Acta Otolaryngol; 1986; 102(5-6):432-7. PubMed ID: 3788543
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vestibular evoked myogenic potential threshold and seasickness susceptibility.
    Tal D; Hershkovitz D; Kaminski G; Bar R
    J Vestib Res; 2006; 16(6):273-8. PubMed ID: 17726280
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of cinnarizine versus sodium valproate in migraine prophylaxis.
    Bostani A; Rajabi A; Moradian N; Razazian N; Rezaei M
    Int J Neurosci; 2013 Jul; 123(7):487-93. PubMed ID: 23311688
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mal de debarquement syndrome: a forgotten entity?
    Murphy TP
    Otolaryngol Head Neck Surg; 1993 Jul; 109(1):10-3. PubMed ID: 8336953
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of Seven Commonly Used Agents for Prophylaxis of Seasickness.
    Schmid R; Schick T; Steffen R; Tschopp A; Wilk T
    J Travel Med; 1994 Dec; 1(4):203-206. PubMed ID: 9815340
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Scopolamine patch to prevent seasickness: clinical response vs. plasma concentration in sailors.
    Gil A; Nachum Z; Dachir S; Chapman S; Levy A; Shupak A; Adir Y; Tal D
    Aviat Space Environ Med; 2005 Aug; 76(8):766-70. PubMed ID: 16110693
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of vestibular training on motion sickness, nystagmus, and subjective vertical.
    Clément G; Deguine O; Bourg M; Pavy-LeTraon A
    J Vestib Res; 2007; 17(5-6):227-37. PubMed ID: 18626134
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Three-years' experience of transdermal scopolamine: long-term effectiveness and side-effects.
    Shupak A; Gordon CR; Spitzer O; Mendelowitz N; Melamed Y
    Pharmatherapeutica; 1989; 5(6):365-70. PubMed ID: 2594820
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug treatment of motion sickness: scopolamine alone and combined with ephedrine in real and simulated situations.
    Tokola O; Laitinen LA; Aho J; Gothoni G; Vapaatalo H
    Aviat Space Environ Med; 1984 Jul; 55(7):636-41. PubMed ID: 6466260
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of cinnarizine on various types of vertigo. Clinical and electronystagmographic results of a double-blind study].
    Hausler R; Sabani E; Rohr M
    Acta Otorhinolaryngol Belg; 1989; 43(2):177-85. PubMed ID: 2690563
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vestibulo-ocular function in anxiety disorders.
    Furman JM; Redfern MS; Jacob RG
    J Vestib Res; 2006; 16(4-5):209-15. PubMed ID: 17538210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.